SEC SCHEDULE 13G

Company

IMMUCELL CORP /DE/

Filed

April 8, 2019

Accession Number

0000846087-19-000061

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →